目的:本研究的目的是比较过去12个月使用戒烟辅助手段(例如,美国食品和药物管理局(FDA)批准的戒烟产品或用于戒烟的电子烟)在有物质使用问题的人(PPSUP)中,目前吸烟给没有物质使用问题的人(SUP),目前在具有全国代表性的美国样本中吸烟。
方法:我们使用了烟草与健康人群评估(PATH)第6波研究[n=30,516]。我们的样本包括成人(18+)已建立的吸烟者(100+每天/非每天使用的终生棒)[n=5,895]。自变量为SUP状态(否,中度,和高)。因变量是过去一年使用的:尼古丁替代疗法(NRT),戒烟药物[即,伐尼克林或安非他酮],或电子烟[用于戒烟和减少吸烟]。每个因变量的加权多变量逻辑回归模型检查了SUP状态和每个戒烟辅助之间的关联,调整对香烟的依赖,每天吸烟,和人口因素。
结果:在吸烟者中,SUP严重程度高的受访者使用NRT的比例更高,戒烟药物,和戒烟的电子烟,分别(12.3%,8.4%,15.7%),与无/低SUP严重程度的患者相比(9.8%,6.0%,8.9%)。在多变量模型中,具有高SUP的受访者使用电子烟戒烟的几率比没有SUP的受访者高63%(95%CI:1.16-2.29)。在高(vs.无/低SUP)在过去一年中使用NRT和戒烟药物。
结论:我们的发现表明,与没有SUP的吸烟者相比,具有高SUP的吸烟者使用电子烟戒烟和减少吸烟的几率更高。
OBJECTIVE: The aim of this study was to compare past 12-month use of cigarette smoking
cessation aids (e.g., Food and Drug Administration (FDA)-approved
cessation products or e-cigarettes for smoking
cessation) among people with substance use problems (PWSUPs) who currently smoke to people without substance use problems (SUPs) who currently smoke cigarettes in a nationally representative US sample.
METHODS: We used the Population Assessment of Tobacco and Health (PATH) Wave 6 Study [n = 30,516]. Our sample comprised adult (18+) established cigarette smokers (100+ lifetime-sticks with daily/non-daily use) [n = 5,895]. The independent variable was SUP status (no, moderate, and high). The dependent variables were past-year use of: nicotine replacement therapies (NRTs), cessation medications [i.e., varenicline or bupropion], or e-cigarettes [for cigarette
cessation and reduction]. Weighted multivariable logistic regression models for each dependent variable examined the associations between SUP status and each cessation aid, adjusting for cigarette dependence, daily cigarette smoking, and demographic factors.
RESULTS: Among people who smoke, a higher proportion of respondents with high SUP severity used NRTs, cessation medications, and e-cigarettes for cigarette
cessation, respectively (12.3%, 8.4%, 15.7%), compared to those with no/low SUP severity (9.8%, 6.0%, 8.9%). In the multivariable models, respondents with high SUPs had 63% (95% CI:1.16-2.29) higher odds of using e-cigarettes for cessation than those without SUPs. No significant differences were seen between high (vs. no/low SUPs) in the past-year use of NRTs and cessation medications.
CONCLUSIONS: Our findings indicate that cigarette smokers with high SUPs had higher odds of using e-cigarettes for cessation and reduction compared to smokers without SUPs.